Substancje stałe doustne: produkcja kliniczna i komercyjna. Dopuszczenia: USFDA, UE (Finlandia), ANVISA.
Pithampur, India

Piramal Pharma Solutions – Hyderabad
Hyderabad

Piramal Pharma Solutions – Rabale
Rabale

Piramal Pharma Solutions – Mahad
Mahad

Piramal Pharma Solutions – Ahmedabad (Formulation Development)
Ahmedabad

Piramal Pharma Solutions – Ahmedabad (Discovery)
Ahmedabad

Piramal Pharma Solutions – Ennore
Ennore

Piramal Pharma Solutions – Turbhe
Turbhe

Piramal Pharma Solutions – Digwal
Digwal

Piramal Pharma Solutions – Aurora
Aurora

Piramal Pharma Solutions – Morpeth
Morpeth

Piramal Pharma Solutions – Grangemouth
Grangemouth

Piramal Pharma Solutions – Lexington
Lexington

Piramal Pharma Solutions – Sellersville
Sellersville

Piramal Pharma Solutions – Riverview
Riverview